JUBA — South Sudan’s Vice President for Gender Cluster, Rebecca Nyandeng De Mabior, on Tuesday received her first jab of AstraZeneca’s COVID-19 vaccine after recovering from the deadly pandemic.
In March, Nyadeng tested positive for the novel coronavirus.
“This Morning the Vice President received her first dose of the Oxford-AstraZeneca vaccine upon the recommendation of her personal physician,” Garang’s office said in a statement posted on Facebook and seen by Sudans Post.
The statement appreciated health workers who took care of her while under coronavirus treatment.
“Rebecca N. de Mabior is grateful to all the health workers and staff who diligently took care of her while she was infected with the virus,” the statement said.
She advised the members of the public to adhere to COVID-19 protocols put in place to protect people against the virus.
“The office of the Vice President encourages all to remain vigilant and adhere to Ministry of Health Guidelines in order to avoid contracting and spreading the virus,” the statement urged.
The World’s youngest nation received 132,000 doses of the AstraZeneca vaccine from the COVAX facility on March 25, 2021.
South Sudan launched its vaccination campaign against COVID-19 in the capital Juba on April 6 and about 947 health workers received the first dose of the AstraZeneca vaccine.